Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
5
×
boston top stories
deals
5
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
cancer immunotherapy
clinical trials
eli lilly
indiana blog main
indiana top stories
johnson & johnson
national
new york blog main
new york top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
investing
medicare
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
abbvie
aduro biotech
agenus
alexion pharmaceuticals
What
companies
5
×
bio
drug
roundup
nash
new
news
price
abandoning
ago
alzheimer’s
approval
approved
arrival
baggage
biogen’s
biopharmaceutical
biotech
convo
cuts
days
deal
development
dicerna
different
digital
disease
earlier
epidemic
fail
failures
fatty
fda
free
frenzied
gene
gets
growing
hasn’t
increases
Language
unset
Current search:
biotech
×
deals
×
" boston blog main "
×
companies
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M